AKR1C2 Antibody

This product is produced by and distributed for Abnova, a company based in Taiwan.

This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. These enzymes catalyze the conversion of aldehydes and ketones to their corresponding alcohols by utilizing NADH and/or NADPH as cofactors. The enzymes display overlapping but distinct substrate specificity. This enzyme binds bile acid with high affinity, and shows minimal 3-alpha-hydroxysteroid dehydrogenase activity. This gene shares high sequence identity with three other gene members and is clustered with those three genes at chromosome 10p15-p14. [provided by RefSeq]

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Showing Publication 1 - 1 of 1.

Publication using H00001646-B02P	Applications	Species
Ebert B, Kisiela M, Wsol V et al. Proteasome inhibitors MG-132 and bortezomib induce AKR1C1; AKR1C3; AKR1B1; and AKR1B10 in human colon cancer cell lines SW-480 and HT-29. Chem Biol Interact 2011-01-06 [PMID: 21215737]

Array H00001646-B02P

• AKR1C2 Antibodies
• AKR1C2 ELISA Kits
• AKR1C2 Lysates
• AKR1C2 Proteins